Target Name: CCR5
NCBI ID: G1234
Review Report on CCR5 Target / Biomarker Content of Review Report on CCR5 Target / Biomarker
CCR5
Other Name(s): chemr13 | chemokine receptor CCR5 | IDDM22 | C-C motif chemokine receptor 5, transcript variant A | Chemokine receptor CCR5 | chemokine recptor CCR5 Delta32 | chemokine (C-C motif) receptor 5 | C-C motif chemokine receptor 5 A159A | C-C CKR-5 | CCR-5 | C-C motif chemokine receptor 5, transcript variant B | Chemokine CCR5 receptor | CMKBR5 | CCR5 variant B | C-C chemokine receptor type 5 | HIV-1 fusion coreceptor | CCR5 variant A | CD195 | FLJ78003 | mutant C-C motif chemokine receptor | CKR-5 | C-C motif chemokine receptor 5 | Chemr13 | CCR5_HUMAN | CHEMR13 | CCCKR5 | CKR5 | CC-CKR-5

CCR5: A Potential Drug Target and Biomarker for Cancer

CCR5, also known as chemr13, is a protein that is expressed in various tissues throughout the body. It is a member of the intercellular signal transducer superfamily and is involved in the regulation of cell signaling pathways. CCR5 has been identified as a potential drug target and is currently being studied as a potential biomarker for various diseases, including cancer.

CCR5 is a protein that is expressed in various tissues throughout the body, including the brain, spinal cord, heart, kidneys, and liver. It is a member of the intercellular signal transducer superfamily and is involved in the regulation of cell signaling pathways. This protein is known to play a role in the development and progression of various diseases, including cancer.

One of the key functions of CCR5 is its role in the regulation of cell signaling pathways. This protein is involved in the signaling pathways that are responsible for the regulation of cell growth, differentiation, and survival. CCR5 helps to regulate the signals that are sent from the cell surface to the cell nucleus, and it is also involved in the regulation of the signals that are sent from the cell nucleus to the cell surface.

CCR5 is also involved in the regulation of the immune response. This protein helps to regulate the movement of immune cells into the site of an infection, and it is also involved in the regulation of the production of antibodies by the immune system.

In addition to its role in cell signaling pathways and the immune response, CCR5 is also involved in the regulation of inflammation. This protein helps to regulate the production of pro-inflammatory cytokines, and it is also involved in the regulation of the movement of immune cells into the site of an infection.

As a potential drug target, CCR5 is being studied for its ability to interfere with the functions of cancer cells. Studies have shown that CCR5 may be able to inhibit the growth and survival of cancer cells, and it may also be able to inhibit the production of pro-inflammatory cytokines. This suggests that CCR5 may be an effective drug target for the treatment of various cancers.

In addition to its potential as a drug target, CCR5 is also being studied as a potential biomarker for various diseases, including cancer. Studies have shown that the levels of CCR5 in certain tissues, such as the bloodstream and the urine, may be able to provide information about the presence and progression of certain diseases. This suggests that CCR5 may be an effective biomarker for the diagnosis and treatment of various diseases.

Overall, CCR5 is a protein that is involved in the regulation of cell signaling pathways and the immune response. As a potential drug target and biomarker, CCR5 is being studied for its ability to interfere with the functions of cancer cells and for its potential use in the diagnosis and treatment of various diseases. Further research is needed to fully understand the role of CCR5 in these processes and to determine its potential as a drug and biomarker.

Protein Name: C-C Motif Chemokine Receptor 5

Functions: Receptor for a number of inflammatory CC-chemokines including CCL3/MIP-1-alpha, CCL4/MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation. Participates in T-lymphocyte migration to the infection site by acting as a chemotactic receptor (PubMed:30713770)

The "CCR5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCR5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCR5AS | CCR6 | CCR7 | CCR8 | CCR9 | CCRL2 | CCS | CCSAP | CCSER1 | CCSER2 | CCT2 | CCT3 | CCT4 | CCT5 | CCT6A | CCT6B | CCT6P1 | CCT6P3 | CCT7 | CCT8 | CCT8L1P | CCT8L2 | CCT8P1 | CCZ1 | CCZ1B | CCZ1P-OR7E38P | CD101 | CD101-AS1 | CD109 | CD14 | CD151 | CD160 | CD163 | CD163L1 | CD164 | CD164L2 | CD177 | CD177P1 | CD180 | CD19 | CD1A | CD1B | CD1C | CD1D | CD1E | CD2 | CD200 | CD200R1 | CD200R1L | CD207 | CD209 | CD22 | CD226 | CD24 | CD244 | CD247 | CD248 | CD24P2 | CD27 | CD27-AS1 | CD274 | CD276 | CD28 | CD2AP | CD2BP2 | CD3 Complex (T Cell Receptor Complex) | CD300A | CD300C | CD300E | CD300LB | CD300LD | CD300LD-AS1 | CD300LF | CD300LG | CD302 | CD320 | CD33 | CD34 | CD36 | CD37 | CD38 | CD3D | CD3E | CD3G | CD4 | CD40 | CD40LG | CD44 | CD44-DT | CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L | CD6